Skip to ContentSkip to Navigation
Practical matters How to find us dr. R.H. Enting

Research interests


Neurological infections



Centralized proton therapy for medulloblastoma; an evaluation of the care infrastructure.

Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome

Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma

11C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

Proton therapy for low grade glioma, who will benefit most?

The Value of Positron Emission Tomography for Differentiating Brain Tumor Progression and Treatment-Induced Changes

Primary Cauda Equina T-Cell Lymphoblastic Lymphoma

Read more